Gross Revenues in FY2009 were $15.1 million, a 31% increase year-over-year as the company began to record the benefits of its multi-product offering and continued to profit from its recurring revenue model and growth in both products and customer base.
Gross Margins including extraordinary items in FY2009 were $8 million, in line with the prior annual period, as the company recorded an extraordinary charge of bad debt in connection with the termination of Devon. Not including the effects of the extraordinary Devon's items, Gross Margins in FY2009 were $10.7 million, a 32% increase year-over-year. Operating Expenses in FY2009 were $3.4 million, a $1.3 million decrease year-over-year, as the company benefited from consolidating intellectual property and research and development activities into a single location, and profiting from the cost advantages associated with in-sourcing of intellectual property and manufacturing operations at Trieste as opposed to Loccioni Group's outsourcing operations at Ancona.
|SOURCE Health Robotics|
Copyright©2010 PR Newswire.
All rights reserved